Skip to main content
. 2018 Aug 7;10:76. doi: 10.1186/s13195-018-0390-y

Fig. 4.

Fig. 4

SCD-plus criteria and risk of preclinical AD. Risk of preclinical AD for each SCD-plus criterion in participants with available amyloid status (n = 114). AD Alzheimer’s disease, APOE apolipoprotein E (genotype), CI confidence interval, OR odds ratio